Clinical Trial Results Affect Several Stocks - Investor's Business Daily PDF Print
Investor's Business DailyAffymax has been working on a drug called Hematide, intended to treat anemia in patients on dialysis because they have end-stage renal disease.

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.